Dodatne informacije

• Lični podaci

• Datum rođenja: 19.02.1976.
• Mesto rođenja: Niš

• Obrazovanje

• Fakultet: Medicinski fakultet Niš
• Odsek / Grupa / Smer: Medicina
• Godina diplomiranja: 2002.

• Spisak publikacija

• Knjige i udžbenici:

  Milošević V. Demencije. U: Đorđević G, Lukić S. (urednici). Neurologija za studente stomatologije. Medicinski fakultet, Niš 2023. ISBN-978-86-6265-117-4.

• Radovi u časopisima sa IMPACT faktorom:
  
  
  1. Milošević V, Bašić J, Semnic M, Antić E, Malobabić M, Stoiljković M. Genetics of Frontotemporal Dementia in the Serbian Population: Findings from a Hospital-Based Cohort. Neurol. Int. 2025; 17: 162. https://doi.org/10.3390/neurolint17100162. IF2₂₀₂₄ = 3,0; IF5₂₀₂₄ = 3,3; JCI₂₀₂₄:0,90; M21
  
  
  2. Stamenović J, Milošević V, Đurić V. Emergency conditions in Parkinson’s disease. AFMN Biomedicine 2025; 42(3):303-312. https://doi.org/10.5937/afmnai42-54569 IF2₂₀₂₄ = 0,3; IF5₂₀₂₄ = 0,4; JCI₂₀₂₄:0,08; M22
  
  
  3. Bašić J, Milošević V, Djordjević B, Stojiljković V, Živanović M, Stefanović N, Aracki Trenkić A, Stojanov D, Jevtović Stoimenov T, Stojanović I. Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer’s Disease. Int. J. Mol. Sci. 2024; 25(11): 5703. https://doi.org/10.3390/ijms25115703  IF2₂₀₂₄ = 4,9; IF5₂₀₂₄ = 5,7; JCI₂₀₂₄:0,71; M21
  
  
  4. Živanović M, Trenkić AA, Milošević V, Stojanov D, Mišić M, Radovanović M, Radovanović V. The role of magnetic resonance imaging in the diagnosis and prognosis of dementia. Biomolecules and Biomedicine. 2023 ;23(2):209. https://doi.org/10.17305/bjbms.2022.8085 IF2₍₂₀₂₃₎ = 3,1; IF5₍₂₀₂₃₎ = 3,3; JCI₂₀₂₃:0,75; M22
  
  
  5. Malobabić M, Stojanov J, Stanojević G, Stević M, Milošević V, Stojanov A. Is the act of mandatory and prolonged in-hospital quarantine a contributing risk factor for impaired mental health among individuals with confirmed COVID-19 infection? Acta facultatis medicae Naissensis. 2023;40(3):344-51. https://doi.org/10.5937/afmnai40-41369 IF2₂₀₂₃ = 0,3;  IF5₂₀₂₃ = 0.3; JCI₂₀₂₃:0,09; M22
  
  
  6. Bašić J, Milošević V, Đorđević B, Stefanović N, Cvetković M, Jevtović-Stoimenov T, Stojanović I. Association of the apolipoprotein E ε4 allele in a Serbian population with Alzheimer’s dementia. Arch Biol Sci. 2023;75(3):319-325. https://doi.org/10.2298/ABS230614026B IF2₍₂₀₂₃₎ = 0,7; IF5₍₂₀₂₃₎ = 0,8; JCI₂₀₂₃:0,18; M23
  
  
  7. Djordjevic G, Milosevic V, Stojanov A. Study of monomelic amyotrophy of the lower limbs in the territory of the Western Balkans: Case series. Medicine (ISSN: 0025-7974). 2023;102(39):e35435. https://doi.org/10.1097/MD.0000000000035435 IF2₍₂₀₂₃₎ = 1,4; IF5₍₂₀₂₃₎ = 1,6; JCI₂₀₂₃:0,35;  M22
  
  
  8. Djordjevic G, Milosevic V, Ljubisavljevic S, Stojanovic I, Stojanov A. Values of Nitric Oxide and Superoxide Dismutase in Cerebrospinal Fluid of Patients with Sporadic Amyotrophic Lateral Sclerosis. Neurol India. 2023;71(4):742-747. https://doi.org/10.4103/0028-3886.383853 IF2 ₍₂₀₂₃₎ = 0,9; IF5 ₍₂₀₂₃₎ = 1,2; JCI₂₀₂₃:0,27;  M23; IF2 ₍₂₀₂₂₎ = 2,7; IF5 ₍₂₀₂₂₎ = 2,6; JCI₂₀₂₂:0,39;  M22 (enauka:M22)
  
  
  9. Milošević V, Malobabić M, Stojanović I, Bašić J. Importance of a functional measure in the evaluation of patients in a memory clinic: Validation of the Serbian version of the Amsterdam instrumental activities of daily living questionnaire. Clin Neurol Neurosurg. 2022;214:107165. https://doi.org/10.1016/j.clineuro.2022.107165 IF2₍₂₀₂₂₎ = 1,9; IF5₍₂₀₂₂₎ = 2,0; JCI₂₀₂₂:0,62;  M22
  
  
  10. Zivkovic Marinkov EM, Rancic NK, Milisavljevic DR, Stankovic MD, Milosevic VD, Malobabic MM, Popovic IN, Ignjatovic AM, Bojanovic MR, Stojanovic JD. Impact of sensorineural hearing loss during the pandemic of Covid-19 on the appearance of depressive symptoms, anxiety and stress. Medicina. 2022;58(2):233. https://doi.org/10.3390/medicina58020233 IF2₍₂₀₂₂₎ = 2,6;  IF5₍₂₀₂₂₎ = 2,9; JCI₂₀₂₂:0,62;  M21
  
  
  11. Bašić J, Milošević V, Živanović M, Kundalić J, Despotović M, Jevtović-Stoimenov T,  Stojanović I. Association of rs780094 and rs1260326 glucokinase regulatory protein gene polymorphisms with dyslipidemia in a group of Serbian acute ischemic stroke patients. Arch Biol Sci. 2022;74(1):41-47. https://doi.org/10.2298/ABS211126002B IF2₍₂₀₂₂₎ = 0,8; IF5₍₂₀₂₂₎ = 0,9; JCI₂₀₂₂:0,21;  M23  IF2₍₂₀₂₀₎ = 0,956; IF5₍₂₀₂₀₎ = 0,943; JCI₂₀₂₀: 0,25 M22 (enauka:M22)
  
  
  12. Joveva E, Ðorđević G, Milošević V, Arsovska A, Živković M. Degree of cognitive impairment in patients with carotid stenosis in relation to cerebral ischemic lesions. Vojnosanit Pregl. 2022;79(2):150-154.  https://doi.org/10.2298/VSP200502082J  IF2₍₂₀₂₂₎ = 0,2; IF5₍₂₀₂₂₎ = 0,2; JCI₂₀₂₂:0,07;  M23
  
  
  13. Stojanov A, Vojinovic S, Stojanov J, Malobabic M, Stevic M, Milosevic V, Stanojevic G. Quality of sleep and fatigue in patients with the relapsing-remitting multiple sclerosis during the coronavirus disease-2019 pandemic. Clin Neurol Neurosurg. 2021:106640. https://doi.org/10.1016/j.clineuro.2021.106640   IF2₍₂₀₂₁₎ = 1,885; IF5₍₂₀₂₁₎ = 2,110; JCI₂₀₂₁:0,57;   M22
  
  
  14. Stojanov J, Malobabic M, Stanojevic G, Stevic M, Milosevic V, Stojanov A. Quality of sleep and health-related quality of life among health care professionals treating patients with coronavirus disease-19. Int J Soc Psychiatry. 2021;67(2):175-181. https://doi.org/10.1177/0020764020942800 IF₍₂₀₂₁₎ = 10,468; IF5₍₂₀₂₁₎ = 6,954; JCI₂₀₂₁:1,09;   M21a
  
  
  15. Stojanov A, Malobabic M, Milosevic V, Stojanov J, Vojinovic S, Stanojevic G, Stevic M. Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak. Mult Scler Relat Dis. 2020;45:102407. https://doi.org/10.1016/j.msard.2020.102407 IF2₍₂₀₂₀₎ = 4,339; IF5₍₂₀₂₀₎ = 4,292;  JCI₂₀₂₀:0,97;   M21
  
  
  16. Stojanov A, Stojanov J, Milosevic V, Malobabic M, Stanojevic G, Stevic M, Djordjevic G. The impact of the Coronavirus Disease-2019 pandemic on the psychological status and quality of life of myasthenia gravis patients. Ann Indian Acad Neurol.  2020;23(4):510-514. https://doi.org/10.4103/aian.AIAN_551_20 IF2₍₂₀₂₀₎ = 1,383; IF5₍₂₀₂₀₎ = 1,626; JCI₂₀₂₀:0,28;   M23
  
  
  17. Stojanov A, Djordjevic G, Stojanov J, Milosevic V, Malobabic M. Validation and cross-cultural adaptation of Columbia Cramp Scale in Serbian ALS patients. Neurol Asia. 2020;25(3): 299 – 304. https://www.neurologyasia.org/articles/neuroasia-2020-25(3)-299.pdf IF2₍₂₀₂₀₎: = 0,183; IF5₍₂₀₂₀₎: = 0,301; JCI₂₀₂₀:0,06;   M23
  
  
  18. Stojanov A, Miloševic V, Ðordevic G, Stojanov J. Quality of Life of Myasthenia Gravis Patients in Regard to Epidemiological and Clinical Characteristics of the Disease. Neurologist 2019;24(4):115-120.  https://doi.org/10.1097/NRL.0000000000000238 IF2₍₂₀₁₉₎ = 0,886; IF5₍₂₀₁₉₎ = 0,933; M23
  
  
  19. Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Sušić G, Lazarević D, Milošević V, Cvetković M, Pavlović D. Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis. Clin Rheumatol. 2019; 38(1):117-124. https://doi.org/10.1007/s10067-018-4264-2 IF2₍₂₀₁₉₎: 2,394; IF2₍₂₀₁₉₎: 2,380; M22
  
  
  20. Stanković M, Bašić J, Milošević V, Nešić M. Oxytocin receptor (OXTR) gene polymorphisms and recognition memory for emotional and neutral faces: A pilot study. Learn Motiv 2019; 67:101577. https://doi.org/10.1016/j.lmot.2019.101577 IF2₍₂₀₁₉₎ = 0,894; IF5₍₂₀₁₉₎ = 1,081; M23;   IF2₍₂₀₁₈₎ = 1,396; IF5₍₂₀₁₈₎ = 1,373; M22 (enauka:M22)
  
  
  21. Bašić J, Milošević V, Stanković M, Jevtović-Stoimenov T, Cvetković T, Despotović M, Pavlović D. The influence of rs53576 and rs2254298 oxytocin receptor gene polymorphisms on plasma oxytocin levels and measures of empathy Arch Biol Sci 2019; 71(1):159-165. https://doi.org/10.2298/ABS181206057B IF2₍₂₀₁₉₎ = 0,719; IF5₍₂₀₁₉₎ = 0.660 M23
  
  
  22. Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Cvetković T, Lazarević D, Sušić G, Milošević V, Cvetković M, Pavlović D. The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis. Rheumatol Int 2019;39(3):551-559. https://doi.org/10.1007/s00296-019-04246-3 IF2₍₂₀₁₉₎ = 1.984; IF5₍₂₀₁₉₎ = 2,056; M22
  
  
  23. Mijajlović MD, Pavlović A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, Hermann DM, Assayag EB, Richard E, Thiel A, Kliper E, Shin Y, Kim YH, Choi S, Jung S, Lee YB, Sinanović O, Levine DA, Schlesinger I, Mead G, Milošević V, Leys D, Hagberg G, Ursin MH, Teuschl Y, Prokopenko S, Mozheyko E, Bezdenezhnykh A, Matz K, Aleksić V, Muresanu D, Korczyn AD, Bornsten NM. Post-stroke dementia – a comprehensive review. BMC Med 2017; 15(1):11. https://doi.org/10.1186/s12916-017-0779-7 IF2₍₂₀₁₇₎ = 9,088; IF5₍₂₀₁₇₎ = 9,410; M21a
  
  
  24. Petrovic J, Milosevic V, Zivkovic M, Stojanov D, Milojkovic O, Kalauzi A, Saponjic J. Slower EEG alpha generation, synchronization and “flow” –possible biomarkers of cognitive impairment and neuropathology of minor stroke. PeerJ 2017; 5: e3839. https://doi.org/10.7717/peerj.3839 IF5₍₂₀₁₇₎ = 2,118; IF5₍₂₀₁₇₎ = 2,469; M21
  
  
  25. Ljubisavljevic S, Milosevic V, Stojanov A, Ljubisavljevic M, Dunjic O, Zivkovic M. Identification of clinical and paraclinical findings predictive for headache occurrence during spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg 2017;158:40-45. https://doi.org/10.1016/j.clineuro.2017.04.017   IF2₍₂₀₁₇₎ = 1,736; IF5₍₂₀₁₇₎ = 1.602; M22
  
  
  26. Stanković M, Nešić M, Obrenović J, Stojanović D, Milošević V. Recognition of facial expressions of emotions in criminal and non-criminal psychopaths: Valence-specific hypothesis. Pers Indiv Differ 2015;82:242-247. https://doi.org/10.1016/j.paid.2015.03.002 IF2₍₂₀₁₅₎ = 1,946; IF5₍₂₀₁₅₎ = 2,417; M21
  
  
  27. Peric S, Milosevic V, Berisavac I, Stojiljkovic O, Beslac-Bumbasirevic L, Marjanovic I, Djuric V, Djordjevic G, Rajic S, Cvijanovic M, Babic M, Dominovic A, Vujovic B, Cukic M, Petrovic M, Toncev G, Komatina N, Martic V, Lavrnic D. Clinical and epidemiological features of Guillain‐Barré syndrome in the Western Balkans. J Peripher Nerv Syst 2014;19(4):317-321. https://doi.org/10.1111/jns.12096  IF2₍₂₀₁₄₎ = 2,758; IF5₍₂₀₁₄₎ = 3,231; M21
  
  
  28. Djuric S, Djuric V, Milosevic V, Mihaljev-Martinov J. The role of neurophysiological methods in the confirmation of brain death. Vojnosanit Pregl 2013;70(3):309-314. https://doi.org/10.2298/VSP110224046D IF2₍₂₀₁₃₎ =0,269; IF5₍₂₀₁₃₎ =0,258; M23
  
  
  29. Milosevic V, Zivkovic M, Djuric S, Vasic V, Kisic Tepavcevic D, Beslac Bumbasirevic Lj, Pekmezovic T. Hospitalizations due to spontaneous intracerebral hemorrhage in the region of Nis (Serbia): 11-year time-series analysis. Clin Neurol Neurosurg 2011;113 (7):552-555. https://doi.org/10.1016/j.clineuro.2011.03.013  IF2₍₂₀₁₁₎ = 1,581; IF5₍₂₀₁₁₎ = 1,581; M22
  
  
  30. Milosevic V, Zivkovic M, Djuric S, Vasic V, Pekmezovic T. Weekly variation of hospital admissions for stroke in Nis (Serbia). Clin Neurol Neurosurg 2010;112 (6):485-489. https://doi.org/10.1016/j.clineuro.2010.03.026 IF2₍₂₀₁₀₎ = 1,636; IF5₍₂₀₁₀₎ = 1,585; M22
  
  
  31. Djuric S, Djuric V, Zivkovic M, Milosevic V, Jolic M , Stamenovic J, Djordjevic G, Machado C. Are somatosensory evoked potentials of the tibial nerve the most sensitive test in diagnosing multiple sclerosis? Neurol India 2010; 58(4):537-541. https://doi.org/10.4103/0028-3886.68669 IF2₍₂₀₁₀₎ =0.834; IF5₍₂₀₁₀₎ =1,108; M23
  
  
  32. Basic J, Pavlovic D, Jevtovic-Stoimenov T, Vojinovic J, Susic G, Stojanovic I, Kocic G, Milosevic V, Cvetkovic T, Marinkovic M, Veljkovic A. Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype. J Physiol Biochem. 2010;66(2):173-80.  https://doi.org/10.1007/s13105-010-0022-x IF2₍₂₀₁₀₎ =1,357; IF5₍₂₀₁₀₎ =1,653; M23
  
  
  33. Djuric S, Djuric V, Zivkovic M, Milosevic V, Stamenovic J, Djordjevic G, Jolic M, Miljkovic S. Diagnostic value of neurophysiological tests in the diagnosis of brain death- Do we need changes in national guidelines? Rev Neurosci 2009;20(3-4):181-186. https://doi.org/10.1515/REVNEURO.2009.20.3-4.181 IF2₍₂₀₀₉₎ =2.600; IF5₍₂₀₀₉₎ =3.007; M22
  
  
  34. Basic J, Golubovic E, Miljkovic P, Bjelakovic G, Cvetkovic T, Milosevic V. Microalbuminuria in Children with Vesicoureteral Reflux. Ren Fail 2008;30:639-643. https://doi.org/10.1080/08860220802134805 IF2₍₂₀₀₈₎= 0.657; IF5 ₍₂₀₀₈₎= 0.907; M23
  
  
• Radovi u ostalim časopisima:
  
  
  1. Bašić J, Milošević V, Đorđević B, Stojiljković V, Živanović M, Jevtović Stoimenov T, Stojanović I. Apolipoprotein E and matrix remodeling – a link to neurodegeneration in Alzheimer’s disease. Biologia Serbica. 2023;45:44-51. https://doi.org/10.5281/zenodo.8361280 (2023:M52; 2022:M24)
  
  
  2. Damjanović R, Cvetković I, Cvetanović M, Milošević V, Stojanov A, Vojinović S, Vrbić M. Longitudinal evaluation of the health-related quality of life in COVID-19 patients: a comparison between pre-infection and three months post-discharge. Acta Medica Medianae. 2024;63(2):15-22. https://doi.org/10.5633/amm.2024.0202 (M52)
  
  
  3. Bašić J, Milošević V, Đorđevic B, Stefanović N, Stojiljkovic V, Jevtović Stoimenov T, Stojanović I.  The influence of the APOE ε4 allele on pro-inflammatory cytokine levels in the cerebrospinal fluid of patients with Alzheimer’s disease. Facta Universitatis Series: Medicine and Biology 2023; 25(2):37-41. https://doi.org/10.22190/FUMB231012006B (2023:M53; 2022: M51)
  
  
  4. Milošević V, Malobabić M, Antić E, Aracki Trenkić A, Stojanov D, Bašić J. Assessment of the instrumental activities of daily living in mild cognitive impairment and dementia due to Alzheimer's disease: Diagnostic accuracy of the Serbian version of the Amsterdam IADL questionnaire. Facta Universitatis Series: Medicine and Biology 2022; 24(2): 35–39. https://doi.org/10.22190/FUMB221215009M (M51)
  
  
  5. Dubbelman MA, Verrijp M, Facal D, Sánchez‐Benavides G, Brown LJ, van der Flier WM, Jokinen H, Lee A, Leroi I, Lojo‐Seoane C, Milošević V, Molinuevo JL,  Rozas AXP, Ritchie C, Salloway S, Stringer G, Zygouris S, Dubois B, Epelbaum S, Scheltens P, Sikkes SAM. The influence of diversity on the measurement of functional impairment: an international validation of the Amsterdam IADL Questionnaire in eight countries. Alzheimer's Dement DADM. 2020;12(1):e12021.  https://doi.org/10.1002/dad2.12021 (M51)
  
  
  6. Bašić J, Milošević V, Despotović M, Jevtović-Stoimenov T, Cvetković T, Živanović M, Živković M, Pavlović D. The influence of CAT-262 C/T polymorphism on catalase activity in patients with ischemic stroke. Acta Medica Medianae 2018;57(4):110-116.  https://doi.org/10.5633/amm.2018.0415  (M51)
  
  
  7. Mitković M, Ristić L, Žikić O, Milošević V, Grbeša G. Percepcija bolesti u hroničnoj ostruktivnoj bolesti pluća. Med Pregl 2010;63(3-4). https://doi.org/10.2298/MPNS1004179M (M51)
  
  
  8. Milošević V, Dačković J, Ocić G, Ilić V, Salak B. Posteriorna kortikalna atrofija – Prikaz slučaja. Praxis Medica 2009; 37(3-4):157-160. (M53)
  
  
  9. Radojkovic D, Radojkovic M, Katic V, Milosevic V, Dakovic J, Angelopoulou T. Citopatoloske karakteristike karcinoma dojke. Acta Medica Medianae 2005;44(2): 57-60. (M52)
  
  
• Radovi na naučnim skupovima međunarodnog značaja:
  
  
  1. Milošević V. Biomarkers of Alzheimer’s disease: contribution to understanding pathogenesis and improving early diagnosis. 8^th Congress of the Macedonian Neurological Society, Ohrid, North Macedonia, 9-12 October 2025. (predavanje po pozivu)
  
  
  2. Milošević V, Bašić J, Djordjević B, Stojiljković V, Stojanović I. Impact of APOE E4 carrier status on plasma irisin levels in Alzheimer's disease patients. International Conference on Alzheimer’s and Parkinson's Diseases and Related Disorders, April 1-5, 2025, Vienna, Austria, p.715. https://info.kenes.com/Flip/ADPD25_ADPD%20-%20Posters/
  
  
  3. Milošević V, Damjanović R, Antić E, Malobabić M, Bašić J, Perić S. Frontotemporal dementia in association with inclusion body myopathy and Paget’s disease: a case report with the VCP gene mutation (c.383G>C). International Conference on Alzheimer’s and Parkinson's Diseases and Related Disorders, March 5-9, 2024, Lisbon, Portugal, p.1339
  
  
  4. Bašić J, Milošević V, Đorđević B, Stojiljković V, Živanović M, Jevtović Stoimenov T, Stojanović I. The interrelation between APOE and matrix metalloproteinase-9 with hippocampal volumetry in patients with Alzheimer’s disease. International Conference on Alzheimer’s and Parkinson's Diseases and Related Disorders, March 5-9, 2024, Lisbon, Portugal, p.1532.
  
  
  5. Milošević V, Malobabić M, Antić E, Damjanović R, Bašić J. Cooking as an activity of daily living in subjects with normal cognition, mild cognitive impairment, and dementia due to Alzheimer’s disease. In: Abstracts from the 17th World Congress on Controversies in Neurology, March 23-25, 2023, in Dubrovnik, Croatia. Restor Neurol Neurosci. 2023;41:5.. https://doi.org/10.3233/RNN-239002
  
  
  6. Basic J, Milosevic V, Djordjevic B, Stojiljkovic V, Malobabic M, Jevtovic Stoimenov T, Stojanovic I. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) as blood biomarkers of Alzheimer’s disease. FEBS Open Bio 2022;12(Suppl 1):125-126.
  
  
  7. Milosevic V, Basic J, Zivkovic M. Early cognitive impairment after minor ischemic stroke. Alzheimer's and Parkinson's Diseases Meeting. 26-31 March 2019, Lisbon, Portugal, p.624
  
  
  8. Milosevic V, Malobabic M, Vukasinovic N, Jolic S, Basic J, Zivkovic M. Low back pain and rapidly progressive cognitive decline as a manifestation of lyme neuroboreliosis: a case report. 11th Congress of the European Pain Federation EFIC, 4-7 September, 2019, Valencia, Spain, eP115
  
  
  9. Bašić J, Vojinović J,  Jevtović-Stoimenov T,  Despotović M,  Lazarević D,  Sušić G, Milošević V, Pavlović D. The influence of rs1001179 polymorphism of the catalase gene on disease activity in patients with juvenile idiopathic arthritis treated with etanercept. 11th Congress of the European Pain Federation EFIC, 4-7 September, 2019, Valencia, Spain, P287
  
  
  10. Milošević V. Instrumental activities of Daily living (IADL) assessment: role in early dementia diagnosis, Adriatic Neurology Forum, Budva, Montenegro, 22.-26.05.2019 (usmeno izlaganje)
  
  
  11. Milosevic V, Basic J, Zivkovic M, Vukasinovic N, Jolic S. Marital status and in-hospital mortality of ischemic stroke. Eur J Neurol 2018;25(Suppl 2): 222.
  
  
  12. Basic J, Milosevic V, Jevtovic Stoimenov T, Despotovic M, Kundalic J, Zivkovic M, Pavlovic D. Glucokinase regulatory protein gene polymorphisms in patients with ischemic stroke. Cerebrovasc Dis 2018;45(Suppl 1):214.
  
  
  13. Milosevic V, Basic J, Vukasinovic N, Jolic S, Zivkovic D, Zivkovic M. Predictors of in-hospital mortality in female patients with ischemic stroke-the influence of marital status. Cerebrovasc Dis 2018;45(Suppl 1):154.
  
  
  14. Milosevic V, Basic J, Vukasinovic N, Jolic S, Zivkovic M. Right hemisphere ischemic stroke in a 24-year-old patient with antithrombin III deficiency presenting as severe oral apraxia and anarthria. Eur J Neurol 2017;24(Suppl 1): 355.
  
  
  15. Petrovic J, Milosevic V, Zivkovic M, Stojanov D, Milojkovic O, Kalauzi A, Saponjic J. EEG alpha is related to the cognitive impairment and „hidden” neuropathology of minor stroke. FENS Regional meeting, 22-23 September 2017, Pecs, Hungary, p. 357 https://pcongress.hu/pdf/petrovic_68_84.pdf
  
  
  16. Milosevic V, Petrovic J, Milojkovic O, Zivkovic M, Saponjic J, Kalauzi A. Frontal EEG alpha changes and cognitive impairment in the subacute minor stroke – preliminary findings. 9th International Congress on Vascular Dementia, 16-18 October, 2015, Ljubljana, Slovenia, p. 22.
  
  
  17. Vukasinovic N, Jolic S, Milosevic V, Zivkovic M, Slankamenac P. Headache as an initial symptom with the patients treated at the intensive care unit of the Clinic of Neurology 1997-2013. The Journal of Headache and Pain 2014;15(Suppl 1):D75
  
  
  18. Vukasinovic N, Jolic S, Milosevic V, Djordjevic G, Cvejic M, Zivkovic M.Intracerebral hemorrhage as the most common cause of brain death in the context of cadaveric organ transplantation. European Journal of Neurology 2014;21:647.
  
  
  19. Vukasinovic N, Jolic S, Milosevic V, Djordjevic G, Cvejic M, Zivkovic M. Non-Inflammatory angiopathy with multiple intracranial aneurysms-case report. Cerebrovascular diseases 2014;37(Suppl 1):394
  
  
  20. Milosevic V, Vukasinovic N, Jolic S, Zivkovic M. Influence of air temperature on the seasonal variations of intracerebral haemorrhage onset:14-year study. Cerebrovascular diseases 2014;37(Suppl 1):614
  
  
  21. Milosevic V, Jolic M, Lazarevic M, Djuric V, Jolic S, Vukasinovic N, Djordjevic G, Zivkovic M. Using photosensor for precise recording of the stimulus onset during N400 event related potentials registration. Journal of Neurologycal Sciences 2013;333:e720.
  
  
  22. Vukasinovic N, Jolic S, Milosevic V, Zivkovic M. Hospitalized patients in the mortality rate from stroke. Journal of Neurologycal Sciences 2013;333:e183
  
  
  23. Milosevic V, Djuric S, Jolic M, Lazarevic M. The N400 component of event-related potentials in multiple sclerosis. European Journal Of Neurology 2012;19:703.
  
  
  24. Djuric V, Milosevic V, Ljubisavljevic S, Stamenovic J,Djordjevic G, Prazic A. Sensitivity of tibial somatosensory evoked potentials in diagnosing patients with relapsing-remitting form of multiple sclerosis. Journal Of Neurology 2011;258:S123.
  
  
  25. Djuric V, Jolic M, Milosevic V, Ljubisavljevic S, Stamenovic J, Prazic A, Djordjevic G, Djuric S. Diagnostic value of vestibular evoked myogenic potential in vertiginous syndrome. Clinical Neurophysiology 2011;122(Suppl 1):S59
  
  
  26. Djuric S, Djuric V, Milosevic V, Stamenovic J, Prazic A, Djordjevic G, Ljubisavljevic S. Segmental evaluation of the somatosensory pathway using median and tibial nerve SEPs in patients with multiple sclerosis. Clinical Neurophysiology 2011;122(Suppl 1):S152
  
  
  27. Ristic S, Ristic D, Vukasinovic N, Milosevic V. Epileptic Seizures in Patients with Cerebrovascular Disease. Epilepsia 2010;51:95.
  
  
  28. Milosevic V, Zivkovic M, Djuric S, Vasic V, Kisic-Tepavcevic D, Pekmezovic T. Seasonal variation in intracerebral haemorrhage hospitalizations in Nis (Serbia): a time-series analysis approach. Journal Of Neurology, 2010;257 (Suppl 1):S201-S202.
  
  
  29. Milosevic V, Zivkovic M, Djuric S, Vasic V, Pekmezovic T.Ten-year study of the influence of meteorological factors on intracerebral haemorrhage hospitalizations in Nis (Serbia). European Journal Of Neurology 2010;17 (Suppl 3):602.
  
  
  30. Milosevic V, Zivkovic M, Djuric S, Vukasinovic N, Pekmezovic T. Temporal patterns of hospital admissions for stroke in Nis (Serbia).European Journal Of Neurology 2009 (Suppl 3);16:608.
  
  
  31. Djuric S, Djuric V, Jolic M, Milosevic V, Stamenovic J, Djordjevic G. Diagnosing value of somatosensory evoked potentials of the tibial nerve in multiple sclerosis.Journal Of The Neurological Sciences 2009;285:S324.
  
  
  32. Vukasinovic N, Jolic S, Cvejic M,  Milosevic V, Zivkovic M.Intravenous tissue-type plasminogen activator therapy for ischaemic stroke: NIS stroke team experience November 2006-February 2009. Journal Of Neurology 2009;256(Suppl 2)0:S212.
  
  
  33. Vukasinovic N, Jolic S, Zivkovic M, Djordjevic G, Ristic S, Prazic A, Milosevic V. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Experience from the Nis stroke unit. European Journal Of Neurology 2008;15(Suppl 3): 268-269.
  
  
  34. Basic J, Golubovic E, Miljkovic P, Bjelakovic G, Cvetkovic T, Milosevic V. Evaluation of tubular damage in children with vesicoureteral reflux. The FEBS Journal 2007; 274(Suppl 1): 286.
  
  
  35. Milosevic V, Manojlovic S. There still is no selective verbal working memory deficit in schizophrenia. 3rd European Working Memory Symposium, Book of abstracts, Genova Italy 2006:40-41
  
  
  36. Basic J, Golubovic E, Miljkovic P, Bjelakovic G,  Milosevic V. Microalbuminuria in children with renal scar as a cosequence of vesicoureteral reflux. FEBS Journal 2006; 273(Suppl 1): 305.
  
  
  37. Basic J, Golubovic E, Miljkovic P, Milosevic V. Microalbuminuria in children with vesicoureteral reflux. Amino Acids 2005; 29: 9-10.
  
  
  38. Basic J, Golubovic E, Miljkovic P, Milosevic V. Evaluation of glomerular damage in children with high grade of vesicoureteral reflux. Biokemia 2005; 29(1 Suppl): 19. 
  
  
• Radovi na domaćim naučnim skupovima:
  
  
  1. Milošević V. Neuroinflamacija u AB – od patogeneze do terapijskog targeta. XXI Kongres neurologa Srbije sa međunarodnim učešćem, Novi Sad, 11-14 decembar 2025. (predavаnje po pozivu)
  
  
  2. Milošević V. Neuroinflamacija u Alchajmerovoj bolesti. 6. Simpozijum o kortikalnim bolestima, Zbornik sažetaka; 23.-25. maj 2025; Sokobanja, Srbija. str 15. (predavanje po pozivu)
  
  
  3. Milošević V. Značaj biomarkera u proceni progresije Alchajmerove bolesti. Interdisciplinarni sastanak: Seminar kliničkog neurologa. Udruženje neurologa Zapadnog Balkana, Bečići, Crna Gora 04-07.04.2024. (predavanje po pozivu)
  
  
  4. Milošević V. Dijagnostika demencija u eri biomarkera: značaj funkcionalnog statusa. U: XIII/XIX Kongres neurologa Srbije sa međunarodnim učešćem, Knjiga sažetaka; 2023; Niš, Srbija. str. 104. (predavanje po pozivu)
  
  
  5. Janković M, Milošević V, Biševac B, Đorđević G. Postinfektivni autoimuni encefalomijelitis kao moguća neurološka komplikacija COVID-19-prikaz slučaja. U: XIII/XIX Kongres neurologa Srbije sa međunarodnim učešćem, Knjiga sažetaka; 2023; Niš, Srbija. str. 190.
  
  
  6. Antić E, Milošević V, Stokanović V. Disekcija unutrašnje karotidne arterije kao moguća komplikacija Eagle sindroma – prikaz slučaja. U: XIII/XIX Kongres neurologa Srbije sa međunarodnim učešćem, Knjiga sažetaka; 2023; Niš, Srbija. str. 174.
  
  
  7. Kalinić S, Malobabić M, Đoković F, Milošević V. Charles Bonnet sindrom: prikaz slučaja. U: XIII/XIX Kongres neurologa Srbije sa međunarodnim učešćem, Knjiga sažetaka; 2023; Niš, Srbija. str. 135.
  
  
  8. Milošević V. Prvi kongres palijativne medicine Srbije: integracija palijativnog zbrinjavanja u lečenju obolelih od maligniteta, neuroloških i plućnih bolesti. Novi Sad 13-14.10.2023. (predavanje po pozivu).
  
  
  9. Milošević V. Covid 19 i progresija demencije i blagog kognitivnog poremećaja – serija slučajeva. Simpozijum Društva neurologa Srbije: COVID 19 i neurologija, Vrdnik 05-07.11.2021. (usmeno izlaganje)
  
  
  10. Milošević V, Malobabić M, Živković M. Deficit instrumentalnih aktivnosti svakodnevnog života kod pacijenata sa blagim kognitivnim poremećajem i demencijom. XII/XVIII kongres neurologa Srbije, Vrnjačka Banja 2019:91.
  
  
  11. Milošević V. Hipoteze etiopatogeneze Alchajmerove bolesti: uloga inflamacije. Nacionalni kongres neurologa, Psihoneuroimunologija, Niš, 26.-29.09.2019. (usmeno izlaganje)
  
  
  12. Milošević V. Sezonske varijacije javljanja moždanog udara. Nacionalni kongres neurologa Niš, 20.-23.09.2018. (usmeno izlaganje)
  
  
  13. Milošević V. Kabinet za kognitivne poremećaje. Nacionalni kongres neurologa Niš, 20.-23.09.2018. (usmeno izlaganje)
  
  
  14. Milošević V.Sezonske varijacije u obolevanju od moždanog udara. XV kongres neurologa Srbije sa medjunarodnim učešćem, Zbornik sažetaka, Beograd 2013:14. (usmeno izlaganje)
  
  
  15. Vukašinović N, Jolić S, Milošević V, Živković M. Intravenska primena terapije aktivatora tkivnog plazminogena u ishemijskom moždanom udaru-iskustva niške jedinice za moždani udar novembar 2006-jun 2013. XV kongres neurologa Srbije sa medjunarodnim učešćem, Zbornik sažetaka, Beograd 2013:169.
  
  
  16. Milošević V. Semantičko pamćenje i komponenta N400 kognitivnih evociranih potencijala. 60. naučno stručni skup psihologa Srbije, Knjiga rezimea, Beograd 2012:22-23.
  
  
  17. Djordjevic G, Djuric S, Milošević V, Djurić V, Ristić S. Amiotrofična lateralna skleroza prezentovana u postpartalnom periodu-prikaz slučaja. XIV Kongres neurologa Srbije sa međunarodnim učešćem, Zbornik radova, Kopaonik 2011:160.
  
  
  18. Milošević V, Antović M, Jolić M, Lazarević M, Djurić V, Djuric S. N400 komponenta evociranih potencijala kao pokazatelj semantičkog odnosa reči u srpskom jeziku. XIV Kongres neurologa Srbije sa međunarodnim učešćem, Zbornik radova, Kopaonik 2011:68. (usmeno izlaganje)
  
  
  19. Milošević V, Antović M, Jolić M, Lazarević M, Djurić V, Djurić S. N400 komponenta evociranih potencijala. Simpozijum kliničke neurofiziologije Srbije i Crne gore sa međunarodnim učešćem, Knjiga sažetaka, Beograd 2011:29-30.
  
  
  20. Milošević V. Uticaj semantičkog odnosa reči u srpskom jeziku na amplitudu komponente N400 kognitivnih evociranih potencijala. Prvi simpozijum iz kognitivnih nauka, Program i zbornik sažetaka predavanja, Niš 2011:15-16. (usmeno izlaganje)
  
  
  21. Milošević V. Nove metode u analizi epidemioloških podataka u moždanom udaru: Hospitalni registar u Nišu. IV simpozijum o cerebrovaskularnim bolestima, Knjiga sažetaka, Beograd 2010:71.
  
  
  22. Milošević V, Živković M, Djurić S, Pekmezović T. Nedeljne i sezonske varijacije u obolevanju od moždanog udara. XIII kongres neurologa Srbije sa medjunarodnim učešćem, Zbornik sažetaka, Kragujevac 2008:220.
  
  
  23. Živadinović B, Milošević V, Kostić V, Savić D, Lukić D, Matijaš M.Moždani udar kod žena. XIII kongres neurologa Srbije sa medjunarodnim učešćem, Zbornik sažetaka, Kragujevac 2008:220-221.
  
  
  24. Pražić A, Živković M, Milošević V. Bolnički registar pacijenata Klinike za neurologiju u Nišu-statistička analiza. XIII kongres neurologa Srbije sa medjunarodnim učešćem, Zbornik sažetaka, Kragujevac 2008:292.
  
  
  25. Đurić S, Đurić V, Stamenović J, Milošević V, Jolić M. Multimodalni evocirani potencijali: Sadašnjost i budućnost. XIII kongres neurologa Srbije sa medjunarodnim učešćem, Zbornik sažetaka, Kragujevac 2008:85.